Life Sciences

Get timely insights into the fast moving Life Sciences industry with news highlighting breakthrough research, biotech advances, regulatory developments, and market shaping trends. This category delivers impactful updates that inform professionals as innovation, technology, and scientific discovery continue to reshape global health and the future of medical progress.

Zebra and Aiva Health Launch Hands-Free Nurse Workflows Platform

Zebra Technologies and Aiva Health have announced a strategic partnership to transform hospital care delivery through voice-driven automation. The collaboration focuses on enabling hands-free nurse workflows, reducing administrative burden, and improving bedside efficiency in modern...

Publication Date: April 10, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Johnson & Johnson Launches VARIPULSE Pro in Europe

Johnson & Johnson has advanced cardiac care innovation by launching VARIPULSE Pro, a next-generation pulsed field ablation technology, across Europe. The company aims to strengthen its electrophysiology portfolio while addressing growing demand for safer atrial...

Publication Date: April 09, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

BD Launches HemoSphere Stream Module for Continuous BP Monitoring

Becton, Dickinson and Company (BD), a renowned global medical technology leader, announced today the launch of the HemoSphere Stream Module, a breakthrough innovation that enhances clinicians’ ability to monitor patient blood pressure continuously and noninvasively....

Publication Date: April 08, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Neurocrine Acquires Soleno to Strengthen Endocrinology and Rare Diseases

In a strategic move aimed at strengthening its foothold in endocrinology and rare diseases, Neurocrine Biosciences announced plans to acquire Soleno Therapeutics for an estimated $2.9 billion in cash, marking a significant milestone in its long‑term...

Publication Date: April 07, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

FDA Approves EYLEA HD for Advanced Eye Treatment

The U.S. Food and Drug Administration has approved EYLEA HD, marking a major advancement in treating serious retinal diseases. The decision strengthens Regeneron Pharmaceuticals’ ophthalmology portfolio while also expanding therapeutic options for patients facing vision-threatening...

Publication Date: April 06, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

FDA Approves Awiqli for Adults with Type 2 Diabetes

The U.S. Food and Drug Administration (FDA) has approved Awiqli, representing a major milestone in diabetes care by enabling once‑weekly basal insulin therapy for adults living with type 2 diabetes. This new treatment, developed by...

Publication Date: March 27, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Thermo Fisher–SHL Medical Forge U.S. Drug Device Solutions Partnership

In a strategic move to strengthen domestic pharmaceutical manufacturing, Thermo Fisher Scientific and SHL Medical announced a collaboration to deliver fully integrated drug‑device solutions, significantly expanding their sterile fill‑finish and autoinjector assembly operations in Ridgefield,...

Publication Date: March 26, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Sonoma Launches Burn Relief Hydrogel in U.S. Retail

Sonoma Pharmaceuticals announced a nationwide retail expansion as it introduced its advanced burn relief hydrogel across major U.S. outlets. The company confirmed that it will distribute the burn relief hydrogel through CVS and Walmart stores,...

Publication Date: March 25, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Cambrex Drives Strategic API Manufacturing Growth in US and Europe

Cambrex, the global contract development and manufacturing organization, announced significant progress in strengthening its active pharmaceutical ingredient (API) manufacturing footprint in both the United States and Europe, setting the stage for future growth in complex...

Publication Date: March 24, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

FDA Approves Nivolumab with Chemotherapy for Advanced Hodgkin Lymphoma

The U.S. Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb Company) in combination with chemotherapy for adult and pediatric patients aged 12 and older with previously untreated, Stage III or IV classical Hodgkin...

Publication Date: March 23, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

News 1 to 10 | Total Count : 77

1

© The News and Media Division of The Insight Partners 2026 | All Rights Reserved | Privacy Policy